I'm A Patient
I'm A ProviderDownload the Clinical Trial
The MacuMira clinical trial, published in the International Journal of Retina and Vitreous, found the following:
100%
of patients in the treatment group showed improved vision
48%
of patients improved by at least 10 letters on the ETDRS acuity chart
8.2 ETDRS letters
Average improvement, along with a 25% average increase in ETDRS acuity
0
adverse effects of treatment
100%
of treated patients maintained their vision improvements for the duration of the trial
Articles
Understanding how dry AMD affects you or your family member can make it a little easier to navigate. Learn more about this eye disease in our articles.
Patients
Eye Care Providers
Select your Country
Corporate:
#302, 815 – 1st Street SW
Calgary, AB
T2P 1N3
info@macumira.com
1-844-619-6263
Mailing Address:
MacuMira Medical Devices Inc
#136 1811 4th Street SW
Calgary, AB
T2S 1W2
Hours:
Mon-Fri: 8am – 5pm
Sat – Sun: Closed